Veru Inc (VERU)

NASDAQ
Currency in USD
0.975
+0.131(+15.40%)
Closed
After Hours
0.970-0.005(-0.513%)
VERU Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
Day's Range
0.8260.993
52 wk Range
0.3611.920
Key Statistics
Edit
Prev. Close
0.844
Open
0.84
Day's Range
0.826-0.993
52 wk Range
0.361-1.92
Volume
4.91M
Average Volume (3m)
1.39M
1-Year Change
163.51%
Book Value / Share
0.22
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VERU Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
3.667
Upside
+276.07%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Veru Inc Company Profile

Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company’s development program includes enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, an oral selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.

Compare VERU to Peers and Sector

Metrics to compare
VERU
Peers
Sector
Relationship
P/E Ratio
−3.8x−1.0x11.7x
PEG Ratio
−0.050.010.03
Price/Book
4.4x1.0x1.5x
Price / LTM Sales
8.5x0.4x0.9x
Upside (Analyst Target)
207.7%62.1%22.8%
Fair Value Upside
Unlock20.8%8.5%Unlock

Analyst Ratings

4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 3.667
(+276.07% Upside)

Earnings

Latest Release
Dec 02, 2024
EPS / Forecast
-0.06 / -0.074
Revenue / Forecast
6.68M / 3.56M
EPS Revisions
Last 90 days

People Also Watch

1.620
INVZ
-5.81%
4.240
LAES
-2.53%
3.100
RR
-5.78%
0.5100
WATT
-3.81%
2.240
QSI
-11.81%

FAQ

What Is the Veru (VERU) Stock Price Today?

The Veru stock price today is 0.975

What Stock Exchange Does Veru Trade On?

Veru is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Veru?

The stock symbol for Veru is "VERU."

What Is the Veru Market Cap?

As of today, Veru market cap is 142.78M.

What is Veru Earnings Per Share?

The Veru EPS is -0.28.

What Is the Next Veru Earnings Date?

Veru will release its next earnings report on 04 Feb 2025.

From a Technical Analysis Perspective, Is VERU a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.